4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-24-018931
Chief Operating Officer bought 36,000 shares at an average $0.64 ($23,051)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cittadine Andrew Chief Operating Officer | 2024-05-29 | Purchase | +12,000 | $0.64 | $7,643 | 69,624 | D |
| Cittadine Andrew Chief Operating Officer | 2024-05-30 | Purchase | +12,000 | $0.64 | $7,676 | 81,624 | D |
| Cittadine Andrew Chief Operating Officer | 2024-05-31 | Purchase | +12,000 | $0.64 | $7,732 | 93,624 | D |
| Open-market purchases · 36,000 sh · avg $0.64 · $23,051 | |||||||
Loading xslF345X05/rdgdoc.xml…